<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7114806/results/search/test_trace/results.xml">
  <result pre="have been used as therapeutic agents for chronic hepatitis C" exact="infection" post="or C-compensated cirrhosis in the conventional treatment. Hepatitis C"/>
  <result pre="brought urgently to our hospital on the same day. Blood" exact="tests" post="and imaging tests were conducted at our hospital on"/>
  <result pre="our hospital on the same day. Blood tests and imaging" exact="tests" post="were conducted at our hospital on the day of"/>
  <result pre="the normal value range at 303 U/mL. Because the possibility of" exact="infection" post="was low based on results of imaging and bronchoalveolar"/>
  <result pre="discontinued, and steroid administration was started. Following steroid pulse therapy," exact="treatment" post="with oral prednisolone tablets was gradually tapered. The patient’s"/>
  <result pre="Interferon (IFN) and ribavirin have been used as the standard" exact="treatment" post="of chronic hepatitis C infection and hepatitis C-compensated cirrhosis."/>
  <result pre="been used as the standard treatment of chronic hepatitis C" exact="infection" post="and hepatitis C-compensated cirrhosis. The first hepatitis C virus"/>
  <result pre="in combination with IFN, but in 2014 an IFN-free DAA" exact="treatment" post="was approved. HARVONI Combination Tablet (ledipasvir acetonate/sofosbuvir [LDV/SOF]; Gilead"/>
  <result pre="or type C-compensated cirrhosis.&quot; This drug was approved for the" exact="treatment" post="of genotype 1 chronic hepatitis C infection in the"/>
  <result pre="approved for the treatment of genotype 1 chronic hepatitis C" exact="infection" post="in the United States in 2014 and in Japan"/>
  <result pre="12 weeks [1, 2]. In the 7th edition of the HCV" exact="treatment" post="guidelines [3], DAAs are mentioned as first-choice drugs that"/>
  <result pre="are mentioned as first-choice drugs that are essential for the" exact="treatment" post="of hepatitis C. Although treatment with IFN has shown"/>
  <result pre="that are essential for the treatment of hepatitis C. Although" exact="treatment" post="with IFN has shown adverse effects in almost all"/>
  <result pre="with IFN has shown adverse effects in almost all patients," exact="treatment" post="with DAAs has few adverse effects and the response"/>
  <result pre="with DAAs has few adverse effects and the response to" exact="treatment" post="is also good as indicated above. DAAs have been"/>
  <result pre="to Sakai City Medical Center. Table 1 Results of blood" exact="tests" post="Blood collection date (mm/dd) 3/24 6/2 6/3 6/4 6/6"/>
  <result pre="transportation, blood tests, chest roentgenogram, computed-tomography scan and urine antigen" exact="tests" post="were conducted at our hospital. Test results showed abnormal"/>
  <result pre="almost normal in the BAL fluid. Because the possibility of" exact="infection" post="was low based on the results of imaging and"/>
  <result pre="with the blood flow and causes direct cell damage by" exact="contact" post="with the endothelial cells of the pulmonary capillaries and"/>
  <result pre="respiratory symptoms improved, and was ended after about 1 month. Steroid" exact="treatment" post="has been shown to be successful in treating allergic"/>
  <result pre="result of a DLST performed two weeks after the steroid" exact="treatment" post="was completed was negative. But the rate of a"/>
  <result pre="a side effect of LDV/SOF. When starting of administration LDV/SOF," exact="treatment" post="for rheumatoid arthritis in the patient had been already"/>
  <result pre="disease was caused drug-induced lung disease due to LDV/SOF. The" exact="diagnosis" post="criteria for drug-induced lung disease caused by hypersensitivity reactions"/>
  <result pre="of pulmonary injury is observed by accidental re-administration. The definitive" exact="diagnosis" post="satisfies items (1) and (4) or (5). The suspicion"/>
  <result pre="Hepatology. JSH guidelines for the management of hepatitis C virus" exact="infection" post="(the 7th edition). https://www.jsh.or.jp/files/uploads/HCV_GL_ver7_02.pdf Accessed 6 Aug 2019. 4.The"/>
 </snippets>
</snippetsTree>
